Clinical Trials in Seattle

Showing 2661-2680 of 4,491 trials

Bortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma

NCT00992446

This phase II trial studies the side effects and how well bortezomib and vorinostat work in treating patients with non-Hodgkin lymphoma (NHL) after patients' own stem cell (autologous) transplant. Bortezomib and vorinostat in the laboratory may stop the growth of lymphoma cells and make them more likely to die by blocking some of the enzymes needed for cell growth. Giving bortezomib together with vorinostat after an autologous stem cell transplant may thus kill lymphoma cells that remain after transplant.

Adult Diffuse Large B-Cell LymphomaB-Cell Non-Hodgkin LymphomaFollicular Lymphoma+3 more

Fred Hutchinson Cancer Center27 participantsStarted Sep 2010

Seattle, Washington, United States

COMPLETEDPhase 1< 1 mile

A Study Of PF-05082566 As A Single Agent And In Combination With Rituximab

NCT01307267

A study of PF-05082566, a 4-1BB agonist monoclonal antibody (mAb), in patients with solid tumors or b-cell lymphomas, and in combination with rituximab in patients with CD20 positive Non-Hodgkin's Lymphoma (NHL).

Lymphoma, Non-HodgkinLymphoma, FollicularLymphoma, Large B-Cell, Diffuse+4 more

Pfizer190 participantsStarted Jun 2011

Duarte, California, United States • La Jolla, California, United States • La Jolla, California, United States +39 more locations

Bortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma

A Study Of PF-05082566 As A Single Agent And In Combination With Rituximab

Find Trials by Condition in Seattle

Cabozantinib or Paclitaxel in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer

A Phase 1 Study of MEDI4736 in Combination With Tremelimumab in Subjects With Advanced Solid Tumors

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination +/- Ribavirin in Adolescents and Children With Chronic HCV-Infection

Study Testing Radium-223 Dichloride in Relapsed Multiple Myeloma

Multi-Center, Randomized, Open-Label Study of G/P +/- RBV for NS5A + SOF Previously Treated GT1 HCV Subjects

Vorinostat, Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Prostate Cancer Intervention Versus Observation Trial (PIVOT)

Impact of Probiotics on Drug, Vitamin, and Hormone Metabolism

Safety and Biological Activity of Vesatolimod in HIV-1 Infected, Virologically Suppressed Adults

A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis

G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes

Evaluate ALLN-177 in Patients With Enteric Hyperoxaluria

A Study to Evaluate Tolerability and Participants Preference Between Mirabegron and Tolterodine Extended Release (ER) in Participants With Overactive Bladder (OAB)

The NEUROlogically-impaired Extubation Timing Trial (NEURO-ETT)

Intervention Research to Reduce HIV Sexual Transmission Among HIV Positive Men Who Have Sex With Men

Sofosbuvir/Velpatasvir in Adults With Chronic Hepatitis C Virus Infection Who Are on Dialysis for End Stage Renal Disease

A Multicenter Randomized 52 Week Treatment Double-blind, Triple Dummy Parallel Group Study to Assess the Efficacy and Safety of QMF149 Compared to Mometasone Furoate in Participants With Asthma

Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101